GTPBP10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.659000E-01
Normal-vs-Stage2
6.179800E-01
Normal-vs-Stage3
5.061600E-01
Normal-vs-Stage4
2.984200E-01
Stage1-vs-Stage2
1.660210E-01
Stage1-vs-Stage3
1.896590E-01
Stage1-vs-Stage4
2.591600E-01
Stage2-vs-Stage3
1.970770E-01
Stage2-vs-Stage4
1.695440E-01
Stage3-vs-Stage4
1.126240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.913800E-01
Normal-vs-AfricanAmerican
4.944600E-01
Normal-vs-Asian
5.530200E-01
Caucasian-vs-AfricanAmerican
5.969400E-01
Caucasian-vs-Asian
4.506600E-01
AfricanAmerican-vs-Asian
7.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.492400E-01
Normal-vs-Female
6.620000E-01
Male-vs-Female
9.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.846000E-01
Normal-vs-Age(41-60Yrs)
3.579200E-01
Normal-vs-Age(61-80Yrs)
8.559200E-01
Normal-vs-Age(81-100Yrs)
8.157800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.192000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.712800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.316000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.904240E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.546810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.337600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.905200E-01
Normal-vs-Daily Drinker
9.677000E-01
Normal-vs-Weekly Drinker
9.563600E-01
Normal-vs-Occasional Drinker
4.086600E-01
Normal-vs-Social Drinker
4.213800E-01
Non Drinker-vs-Daily Drinker
6.966600E-01
Non Drinker-vs-Weekly Drinker
7.201600E-01
Non Drinker-vs-Occasional Drinker
1.195630E-01
Non Drinker-vs-Social Drinker
2.764400E-01
Daily Drinker-vs-Weekly Drinker
9.753400E-01
Daily Drinker-vs-Occasional Drinker
6.099600E-02
Daily Drinker-vs-Social Drinker
1.254220E-01
Weekly Drinker-vs-Occasional Drinker
1.054840E-01
Weekly Drinker-vs-Social Drinker
1.643850E-01
Occasional Drinker-vs-Social Drinker
6.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.540440E-01
Normal-vs-Grade 2
3.750100E-02
Normal-vs-Grade 3
2.849600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.093180E-01
Grade 1-vs-Grade 3
2.544400E-02
Grade 1-vs-Grade 4
1.540440E-01
Grade 2-vs-Grade 3
2.195800E-01
Grade 2-vs-Grade 4
3.750100E-02
Grade 3-vs-Grade 4
2.849600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.062600E-01
Normal-vs-NonDiabetic
6.225000E-01
Diabetic-vs-NonDiabetic
2.434300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.894200E-01
Normal-vs-NoPancreatitis
7.120200E-01
Pancreatitis-vs-NoPancreatitis
6.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.857600E-01
Normal-vs-N1
6.430800E-01
N0-vs-N1
5.374200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.356400E-01
Normal-vs-TP53-NonMutant
6.574800E-01
TP53-Mutant-vs-TP53-NonMutant
2.785700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
